These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 9055905

  • 41. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
    Geffner M, Lundberg M, Koltowska-Häggström M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
    [Abstract] [Full Text] [Related]

  • 42. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 43. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ, van der Kaay DC, de Ridder MA, Bakker-van Waarde WM, van der Hulst FJ, Mulder JC, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Sulkers EJ, Westerlaken C, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [Abstract] [Full Text] [Related]

  • 44. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW, Willemsen RH, van der Kaay DC, van Dijk M, Visser TJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [Abstract] [Full Text] [Related]

  • 45. Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year.
    Ranke MB, Martin DD, Ehehalt S, Schwarze CP, Serra F, Wollmann HA, Schweizer R.
    Horm Res Paediatr; 2011 Aug; 76(2):104-12. PubMed ID: 21757866
    [Abstract] [Full Text] [Related]

  • 46. New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial.
    Renes JS, Willemsen RH, Mulder JC, Bakker-van Waarde WM, Rotteveel J, Oostdijk W, Houdijk EC, Westerlaken C, Noordam C, Verrijn Stuart AA, Odink RJ, de Ridder MA, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):854-61. PubMed ID: 25409576
    [Abstract] [Full Text] [Related]

  • 47. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
    Tamaro G, Pizzul M, Gaeta G, Servello R, Trevisan M, Böhm P, Materassi PMA, Macaluso A, Valentini D, Pellegrin MC, Barbi E, Tornese G.
    Ital J Pediatr; 2021 Apr 01; 47(1):82. PubMed ID: 33794966
    [Abstract] [Full Text] [Related]

  • 48. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R.
    Curr Pharm Biotechnol; 2000 Jul 01; 1(1):33-46. PubMed ID: 11467359
    [Abstract] [Full Text] [Related]

  • 49. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
    Labarta JI, de Arriba A, Ferrer M, Loranca M, Martos JM, Rodríguez A, Samaniego ML, Sánchez-Cenizo L.
    J Pediatr Endocrinol Metab; 2020 Jul 28; 33(7):923-932. PubMed ID: 32623373
    [Abstract] [Full Text] [Related]

  • 50. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Jul 28; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 51. Growth hormone treatment induces a dose-dependent catch-up growth in short children born small for gestational age: a summary of four clinical trials.
    Wilton P, Albertsson-Wikland K, Butenandt O, Chaussain JL, de Zegher F, Jonsson B, Löfström A.
    Horm Res; 1997 Jul 28; 48 Suppl 1():67-71. PubMed ID: 9161875
    [Abstract] [Full Text] [Related]

  • 52. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov 28; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 53. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis.
    Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP, Saenger P.
    Horm Res; 2006 Nov 28; 65 Suppl 3():153-9. PubMed ID: 16612129
    [Abstract] [Full Text] [Related]

  • 54. Prediction factors in the determination of final height in subjects born small for gestational age.
    Leger J, Limoni C, Collin D, Czernichow P.
    Pediatr Res; 1998 Jun 28; 43(6):808-12. PubMed ID: 9621992
    [Abstract] [Full Text] [Related]

  • 55. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA, Longui CA, Kochi C, Arruda M, Faria CD, Calliari LE, Monte O, Pachi PR, Saenger P.
    Horm Res; 2009 Jun 28; 72(5):275-80. PubMed ID: 19844113
    [Abstract] [Full Text] [Related]

  • 56. Long-term effectiveness of growth hormone therapy in children born small for gestational age: An analysis of LG growth study data.
    Lee HS, Kum CD, Rho JG, Hwang JS.
    PLoS One; 2022 Jun 28; 17(4):e0266329. PubMed ID: 35472208
    [Abstract] [Full Text] [Related]

  • 57. Growth hormone treatment for short stature in children born small for gestational age.
    Jung H, Rosilio M, Blum WF, Drop SL.
    Adv Ther; 2008 Oct 28; 25(10):951-78. PubMed ID: 18836868
    [Abstract] [Full Text] [Related]

  • 58. A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study.
    De Schepper J, Vanderfaeillie J, Mullis PE, Rooman R, Robertson A, Dilleen M, Gomez R, Wollmann HA.
    Clin Endocrinol (Oxf); 2016 Mar 28; 84(3):353-60. PubMed ID: 26501737
    [Abstract] [Full Text] [Related]

  • 59. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW, Willemsen RH, van der Kaay DC, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Apr 28; 70(4):582-7. PubMed ID: 19067725
    [Abstract] [Full Text] [Related]

  • 60. Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and small-for-gestational-age (SGA) children.
    Schweizer R, Martin DD, Haase M, Roth J, Trebar B, Binder G, Schwarze CP, Ranke MB.
    Bone; 2007 Nov 28; 41(5):875-81. PubMed ID: 17826368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.